// App-Quantinova.ai

e20528 : A bayesian network comparison of different agents or regimens as first-line treatment for advanced EGFR-mutated NSCLC.

Researchers

Presenter

  • Wenhua Liang

Principal Investigators

  • Qihua He

  • Jianrong Zhang

  • Long Jiang

  • Caicun Zhou

  • Jianxing He

Medical Centers

  • Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease., Guangzhou, China

  • The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, CA, China

  • The First Affiliated Hospital of Guangzhou Medical University & Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease, Guangzhou, China

  • Shanghai Pulmonary Hospital, Shanghai, China

  • The First Affiliated Hospital of Guangzhou Medical College, Guangzhou,Guangdong Province, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • II/III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved